Bon Secours Health System in Ireland chooses Hyland Healthcare to manage clinical content enterprise-wide

Bon Secours Health System, the largest private health care provider in Ireland, has selected OnBase, Hyland's enterprise information platform, to digitize and manage clinical documents. The platform will optimize workflows and performance across the enterprise,...

RSNA 2020 Registration Tops 14,000 Six Weeks Ahead of Meeting

With strong advance registration numbers, the Radiological Society of North America (RSNA) 106th Scientific Assembly and Annual Meeting (RSNA 2020) is shaping up to be a success. Six weeks ahead of the meeting, 14,125 people from countries around the world are already...

Varian Stockholders Approve Combination with Siemens Healthineers

Varian has announced that its stockholders have voted to approve the previously announced pending combination with Siemens Healthineers AG at a special meeting. Varian stockholders voted overwhelmingly in favor of the transaction. "The overwhelming support our...

See-Mode Technologies Receives FDA Clearance for AI Software

See-Mode Technologies, a MedTech startup based in Singapore and Australia that seeks to empower clinicians to better predict stroke, has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its debut product, Augmented...

Fujifilm ASPIRE Cristalle with Tomosynthesis and Simulated 2D

Fujifilm’s innovative engineering and advanced image processing has created a high sensitivity mammography system for low dose and exceptional image quality. Featuring patented Comfort paddles, Fujifilm’s ASPIRE Cristalle with Digital Breast Tomosynthesis (DBT) is designed to more comfortably adapt to individual breast shape and minimize pinch points. Its recent S-View feature generates an excellent quality synthetic 2D image from the 3D images at almost half the dose of a 3D and dedicated 2D view combined. Today, more than 9,000 global customers trust Fujifilm Digital Mammography Solutions. •

For more information, visit:



Submit a Comment

Your email address will not be published. Required fields are marked *